Show Summary Details
Page of

Acquired metabolic disorders and the nervous system 

Acquired metabolic disorders and the nervous system
Chapter:
Acquired metabolic disorders and the nervous system
Author(s):

Neil Scolding

DOI:
10.1093/med/9780198746690.003.0614
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 27 February 2021

Metabolic diseases and their neurological complications require a knowledge of both general internal medicine and of neurology - one reason why they are often poorly handled clinically. They range from the neurological complications of hypercalcaemia to dramatic, serious, and not uncommon neurological picture of central pontine myelinolysis and its still uncertain metabolic cause(s); from the emergence of new(-ish) disorders such as superficial siderosis and E-induced water intoxication to the changing face and context of iatrogenic Cushing’s syndrome, chemotherapy-induced nutritional and metabolic disruption. This brief and partial list helps to emphasize the importance and impact of acquired neurometabolic diseases. This chapter aims to deal with these, or to point elsewhere in this text to where they are covered.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.